Galia Rahav to Secondary Prevention
This is a "connection" page, showing publications Galia Rahav has written about Secondary Prevention.
Connection Strength
0.154
-
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence. Clin Infect Dis. 2018 08 16; 67(5):649-656.
Score: 0.126
-
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. N Engl J Med. 2017 01 26; 376(4):305-317.
Score: 0.028